Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
700K
-
Number of holders
-
0
-
Total 13F shares, excl. options
-
0
-
Shares change
-
-2.13M
-
Total reported value, excl. options
-
$0
-
Value change
-
-$1.05M
-
Number of sells
-
-15
Significant Holders of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) as of Q2 2025
15 filings reported holding RNAZ - TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value as of Q2 2025.
TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) has 0 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 0 shares
of 700K outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Ground Swell Capital, LLC (0 shares), COMMONWEALTH EQUITY SERVICES, LLC (0 shares), SouthState Corp (0 shares), ACADIAN ASSET MANAGEMENT LLC (0 shares), SBI Securities Co., Ltd. (0 shares), Warberg Asset Management LLC (0 shares), CORSAIR CAPITAL MANAGEMENT, L.P. (0 shares), BANK OF AMERICA CORP /DE/ (0 shares), FMR LLC (0 shares), and MORGAN STANLEY (0 shares).
This table shows the top 0 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.